Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
akcea therapeutics
anylam pharmaceuticals
boston blog main
boston top stories
cardiomyopathy
clinical trials
drugs
inotersen
life sciences
national blog main
national top stories
neuropathy
new york
new york blog main
new york top stories
onpattro
patisiran
pfizer
san diego blog main
san diego top stories
tafamidis
tegsedi
transthyretin amyloidosis
What
fda
2
×
genetic
2
×
pfizer
2
×
ago
agreement
akcea
alnylam
amyloidosis
ancestry
andme
announced
approved
attr
available
battle
company
data
deal
debilitating
disease
drug
following
genentech
genetics
giant
hard
heels
languishing
medical
medicines
million
offer
oks
patients
permitted
personal
pharmaceutical
platform
rare
raw
Language
Current search:
pfizer
×
genetic
×
fda
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@theverge.com
9 years ago
23andMe to offer users' medical data to Pfizer for research